---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-046847"
form_type: "8-K/A"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2026-10-13T20:45:18+00:00"
generated_at: "2026-10-13T20:46:07.169635+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Glucotrack restates Lokahi merger pro forma for 1-for-15 reverse split; H1 2026 pro forma net loss $19.7M

## Summary
- Lokahi merger closed July 14, 2026; 5,323,013 common-equivalent shares issued, valued at $33.33M ($6.261/share).
- Purchase price allocated to $25.4M in-process R&D/intangibles and $14.67M goodwill; liabilities assumed $9.24M.
- Pro forma H1 2026 net loss $19.70M (no revenue); FY2025 pro forma net loss $28.14M, EPS loss $236.97.
- Bridge: $4.45M gross (face $5.71M, 22% OID, 8% coupon, due 4/14/27) plus $3.5M follow-on (due 5/4/27).
- 1-for-15 split effective Aug 28, 2026; ELOC allows up to $50M of stock sales over 3 years, none sold.

## SEC filing metadata
- accession: 0001493152-26-046847
- form_type: 8-K/A
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2026-10-13T20:45:18+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315226046847/0001493152-26-046847-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315226046847/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-046847
- JSON: https://secwatch.observer/filing/0001493152-26-046847.json
- Plain text: https://secwatch.observer/filing/0001493152-26-046847.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.